Previous EU Guidance Wrong On Format Rule For Mutual Recognition Procedures
Executive Summary
Contrary to previous guidance, applicants must submit as of Jan 1 all MRP submissions in eCTD format, including submissions for ongoing regulatory activities which may not have been originally submitted in this format.
You may also be interested in...
Some Adverse Events For Generics Still Should Not Be Submitted Through eCTD Portal, US FDA Says
Implementation of eCTD regulations for commercial INDs did not change system for submitting premarket bioavailability/bioequivalence study reports intended to support ANDA approval, agency clarifies.
Some Adverse Events For Generics Still Should Not Be Submitted Through eCTD Portal, US FDA Says
Implementation of eCTD regulations for commercial INDs did not change system for submitting premarket bioavailability/bioequivalence study reports intended to support ANDA approval, agency clarifies.
Canada Allows Exemptions To Mandatory eCTD Format In Justified Cases
Drug sponsors operating in Canada might be able to get an exemption from a new requirement that as of Jan. 1 required them to start filing certain regulatory activities in the electronic common technical document (eCTD) format